专利检索 ap:("KLING BIOTHERAPEUTICS B.V.") AND inv:"Adrianus Quirinus Bakker" 第 1 页

1.

发明授权
Means and methods for counteracting myeloproliferative or lymphoproliferative disorders 有权

公开(公告)号：US11629200B2

公开(公告)日：2023-04-18

申请号：US16733376

申请日：2020-01-03

申请人： KLING BIOTHERAPEUTICS B.V.

发明人： Hergen Spits , Tim Beaumont , Marijn Aletta Gillissen , Adrianus Quirinus Bakker , Mette Deborah Hazenberg , Martijn Kedde

IPC分类号： C07K16/30 , C07K16/06 , A61K47/68 , C07K16/40 , C12P21/00 , G01N33/574

摘要： The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.